Molly Stevens
Direttore/Membro del Consiglio presso The National Gallery
Profilo
Molly M.
Stevens was the founder of RepRegen Ltd.
(founded in 2006) and served as the Director & Chief Scientific Officer from 2006 to 2013.
Dr. Stevens is also the founder of SPARTA Biodiscovery Ltd.
Dr. Stevens's current jobs include being a Professor at Imperial College London, a Trustee at The National Gallery (since 2018), and an Advisor at Impact Investment Partners LLP.
Dr. Stevens completed her undergraduate degree at the University of Bath in 1995 and obtained her doctorate from Nottingham Trent University in 2000.
Posizioni attive di Molly Stevens
| Società | Posizione | Inizio |
|---|---|---|
| Imperial College London | Corporate Officer/Principal | - |
The National Gallery
 The National Gallery Other Consumer ServicesConsumer Services The National Gallery operates museums and art galleries. Its collections include beginner's guides, artists at a glance, collection explorer, full index, study and care, national inventory, and picture library. The company was founded in April 1824 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 02/07/2018 |
Impact Investment Partners LLP
 Impact Investment Partners LLP Investment ManagersFinance Impact Investment Partners LLP (Impact Investment Partners) is a private equity firm founded in 2010 by Varun Sahni and Nadia Sood. The firm is headquartered in London, United Kingdom. | Consulente / Consigliere | - |
Precedenti posizioni note di Molly Stevens
| Società | Posizione | Fine |
|---|---|---|
RepRegen Ltd.
 RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Fondatore | 07/03/2013 |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology SPARTA Biodiscovery Ltd. manufactures instruments for chemical analysis and pharmaceutical research. The company is based in London, UK. The British company was founded by Molly M. Stevens. The CEO is Jelle Penders. | Fondatore | - |
Formazione di Molly Stevens
| University of Bath | Undergraduate Degree |
| Nottingham Trent University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The National Gallery
The National Gallery Other Consumer ServicesConsumer Services The National Gallery operates museums and art galleries. Its collections include beginner's guides, artists at a glance, collection explorer, full index, study and care, national inventory, and picture library. The company was founded in April 1824 and is headquartered in London, the United Kingdom. | Consumer Services |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Health Services |
Impact Investment Partners LLP
Impact Investment Partners LLP Investment ManagersFinance Impact Investment Partners LLP (Impact Investment Partners) is a private equity firm founded in 2010 by Varun Sahni and Nadia Sood. The firm is headquartered in London, United Kingdom. | Finance |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology SPARTA Biodiscovery Ltd. manufactures instruments for chemical analysis and pharmaceutical research. The company is based in London, UK. The British company was founded by Molly M. Stevens. The CEO is Jelle Penders. | Health Technology |
- Borsa valori
- Insiders
- Molly Stevens
